5 alpha dihydrotestosterone formulations and associated methods of use and treatment
OwnerEdward Dunne Corboy, Jr.inventor
Life of this patent
Estimating the term…
Abstract
Disclosed are pharmaceutical and cosmetic compositions that include 5 Alpha Dihydrotestosterone (or alternatively, 5α-DHT, 5 Alpha-DHT, 5 Alpha DHT, 5a-DHT, DHT), and associated methods of use and treatment that can be used alone or in combination with other treatments to provide, improve, or promote general well-being and health, including mental health, in a subject. In particular the compositions, methods, and uses can provide, promote, support, and/or improve outcomes associated with gender reassignment, gender transitioning, and/or gender-affirming therapy in a subject who may be in need thereof.
Claims17
A method of supportive treatment in female to male transgender males with gender dysphoria receiving gender affirming hormone therapy comprising topically administering a composition or pharmaceutical formulation of 5 Alpha Dihydrotestosterone (5 Alpha-DHT), or a pharmaceutically acceptable salt or ester thereof, to the patient in an amount effective to promote hair growth;
- and
- wherein the concentration of 5 Alpha-DHT in the composition or pharmaceutical formulation is selected from the group consisting of (i) ranges from about 0.00001% to about 50% weight to weight;
- (ii) ranges from 0.00001% to about 50%, weight to volume;
- and (iii) ranges from about 0.00001% to about 50%, volume to volume;
- wherein the method promotes hair growth on the face, body, or pubic region of the patient;
- and
- wherein the 5 Alpha-DHT composition or pharmaceutical formulation further comprises one or more dermal penetration enhancement agents that optimize hair follicle and hair shaft absorption when applied topically.
Dependencies are inferred from the claim text.